Uterine neoplasms in patients treated with tamoxifen
Copyright policy )Uterine neoplasms in patients treated with tamoxifen
Since 1985, when Killackey originally described three cases of endometrial carcinoma in patients receiving tamoxifen, there have been several reports confirming or denying the relationship between tamoxifen and endometrial carcinoma. Our study of 15 patients treated for breast carcinoma with tamoxifen found that papillary serous carcinoma was the most common tumor in this group of patients. Several other retrospective studies reported a high incidence of high-grade endometrioid adenocarcinoma or high-risk variants of endometrial carcinoma in patients receiving tamoxifen.
- The University of Texas System United States
- The University of Texas MD Anderson Cancer Center United States
- The University of Texas at Austin United States
Tamoxifen, Polyps, Antineoplastic Agents, Hormonal, Incidence, Endometrial Hyperplasia, Humans, Breast Neoplasms, Female, Neoplasms, Second Primary, Endometrial Neoplasms
Tamoxifen, Polyps, Antineoplastic Agents, Hormonal, Incidence, Endometrial Hyperplasia, Humans, Breast Neoplasms, Female, Neoplasms, Second Primary, Endometrial Neoplasms
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).15 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!